Specified Drug Use Survey on AJOVY Subcutaneous Injection for Long-term Use

NCT05342493 · clinicaltrials.gov ↗

RECRUITING

Status

1000

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine Disorders

Interventions

DRUG: Fremanezumab 225 Mg/1.5 mL Subcutaneous Solution

Sponsor

Otsuka Pharmaceutical Co., Ltd.